Neural tissue engineering using embryonic and induced pluripotent stem cells

With the recent start of the first clinical trial evaluating a human embryonic stem cell-derived therapy for the treatment of acute spinal cord injury, it is important to review the current literature examining the use of embryonic stem cells for neural tissue engineering applications with a focus on diseases and disorders that affect the central nervous system. Embryonic stem cells exhibit pluripotency and thus can differentiate into any cell type found in the body, including those found in the nervous system. A range of studies have investigated how to direct the differentiation of embryonic cells into specific neural phenotypes using a variety of cues to achieve the goal of replacing diseased or damaged neural tissue. Additionally, the recent development of induced pluripotent stem cells provides an intriguing alternative to the use of human embryonic stem cell lines for these applications. This review will discuss relevant studies that have used embryonic stem cells to replicate the tissue found in the central nervous system as well as evaluate the potential of induced pluripotent stem cells for the aforementioned applications.

[1]  C. Olanow,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[2]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[3]  T. Perlmann,et al.  Neuronal cell replacement in Parkinson’s disease , 2009, Journal of internal medicine.

[4]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[5]  Miranda Yap,et al.  Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin‐Like Protein‐1 , 2008, Stem cells.

[6]  C. Freed,et al.  Noggin Enhances Dopamine Neuron Production from Human Embryonic Stem Cells and Improves Behavioral Outcome After Transplantation into Parkinsonian Rats , 2008, Stem cells.

[7]  M. Rao.  Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. , 2004, Developmental biology.

[8]  Bruce G. Jenkins,et al.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Elena Cattaneo,et al.  Neural stem cell systems: physiological players or in vitro entities? , 2010, Nature Reviews Neuroscience.

[10]  J. Rothstein,et al.  Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  David Parker,et al.  Neuronal network analyses: premises, promises and uncertainties , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[12]  J. Obeso,et al.  Dopaminergic transplantation for parkinson's disease: Current status and future prospects , 2009, Annals of neurology.

[13]  Jihwan Song,et al.  Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions , 2007, Neuroscience Letters.

[14]  James A Thomson,et al.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency , 2010, Proceedings of the National Academy of Sciences.

[15]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[16]  Jin Woo Chang,et al.  Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[17]  Kwang-Soo Kim,et al.  Stromal Cell–Derived Inducing Activity, Nurr1, and Signaling Molecules Synergistically Induce Dopaminergic Neurons from Mouse Embryonic Stem Cells , 2006, Stem cells.

[18]  Elena M. Vazey,et al.  Comparison of Transplant Efficiency between Spontaneously Derived and Noggin-Primed Human Embryonic Stem Cell Neural Precursors in the Quinolinic Acid Rat Model of Huntington's Disease , 2010, Cell transplantation.

[19]  E. Benarroch.  Central neuron-glia interactions and neuropathic pain , 2010, Neurology.

[20]  S. Heilshorn,et al.  Biomaterial design strategies for the treatment of spinal cord injuries. , 2010, Journal of neurotrauma.

[21]  E. Cattaneo,et al.  Neural stem cell systems: physiological players or in vitro entities? , 2010, Nature Reviews Neuroscience.

[22]  Vesna Sossi,et al.  A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.

[23]  T. Tamiya,et al.  Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. , 2006, The journal of medical investigation : JMI.

[24]  Victoria Moreno-Manzano,et al.  Transplanted Oligodendrocytes and Motoneuron Progenitors Generated from Human Embryonic Stem Cells Promote Locomotor Recovery After Spinal Cord Transection , 2010, Stem cells.

[25]  Jean A. Orman,et al.  The Epidemiology of Traumatic Brain Injury , 2010, The Journal of head trauma rehabilitation.

[26]  Hideyuki Okano,et al.  Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury , 2010, Proceedings of the National Academy of Sciences.

[27]  H. Keirstead,et al.  Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. , 2006, Regenerative medicine.

[28]  M. Molcanyi,et al.  Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain. , 2007, Journal of neurotrauma.

[29]  D. Nisbet,et al.  Biomaterials for spinal cord regeneration: Outgrowth of presumptive neuronal precursors on electrospun poly(ε)-caprolactone scaffolds microlayered with alternating polyelectrolytes , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[30]  S. Willerth,et al.  The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. , 2008, Stem cell research.

[31]  Hossein Baharvand,et al.  Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. , 2009, Cytotherapy.

[32]  World's first clinical trial of human embryonic stem cell therapy cleared. , 2009, Regenerative medicine.

[33]  M. Mascalchi,et al.  Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation , 2010, Experimental Neurology.

[34]  T. Croll,et al.  Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. , 2007, Regenerative medicine.

[35]  A. Webb,et al.  Spinal cord injury I: A synopsis of the basic science. , 2010, The Canadian veterinary journal = La revue veterinaire canadienne.

[36]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[37]  S. Mayor.  First patient enters trial to test safety of stem cells in spinal injury , 2010, BMJ : British Medical Journal.

[38]  S. Willerth,et al.  Approaches to neural tissue engineering using scaffolds for drug delivery. , 2007, Advanced drug delivery reviews.

[39]  C. Freed,et al.  Generation of Tyrosine Hydroxylase Positive Neurons from Human Embryonic Stem Cells after Coculture with Cellular Substrates and Exposure to GDNF , 2004, Stem cells.

[40]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[41]  S. Frank,et al.  Long-term fetal cell transplant in Huntington disease: Stayin’ alive , 2007, Neurology.

[42]  K. Krause,et al.  Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy , 2008, The Journal of pathology.

[43]  C. Fong,et al.  Teratomas from pluripotent stem cells: A clinical hurdle , 2010, Journal of cellular biochemistry.

[44]  M. Jacquin,et al.  Transplantation of apoptosis-resistant embryonic stem cells into the injured rat spinal cord , 2005, Somatosensory & motor research.

[45]  L. Schoonjans,et al.  Embryonic Stem Cells: Similarities and Differences Between Human and Murine Embryonic Stem Cells , 2006, American journal of reproductive immunology.

[46]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[47]  Jason R. Thonhoff,et al.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis. , 2009, Current stem cell research & therapy.

[48]  M. Peschanski,et al.  Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats , 2008, Proceedings of the National Academy of Sciences.

[49]  M. Sakakibara,et al.  Introduction of the MASH1 gene into mouse embryonic stem cells leads to differentiation of motoneuron precursors lacking Nogo receptor expression that can be applicable for transplantation to spinal cord injury , 2006, Neurobiology of Disease.

[50]  M. Soleimani,et al.  Repair of spinal cord injury by co-transplantation of embryonic stem cell-derived motor neuron and olfactory ensheathing cell. , 2009, Iranian biomedical journal.

[51]  Martin Pera,et al.  Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats , 2004, Stem cells.

[52]  H. Baharvand,et al.  Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. , 2009, Differentiation; research in biological diversity.

[53]  N. Thakor,et al.  Efficient Differentiation of Human Embryonic Stem Cells into Oligodendrocyte Progenitors for Application in a Rat Contusion Model of Spinal Cord Injury , 2010, The International journal of neuroscience.

[54]  K. Sethi.  The Impact of Levodopa on Quality of Life in Patients With Parkinson Disease , 2010, The neurologist.

[55]  M. Glazova,et al.  Predifferentiated Embryonic Stem Cells Prevent Chronic Pain Behaviors and Restore Sensory Function Following Spinal Cord Injury in Mice , 2006, Molecular Medicine.

[56]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[57]  S. Madduri,et al.  Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration , 2010, Journal of the peripheral nervous system : JPNS.

[58]  D. Gottlieb,et al.  The Effects of Soluble Growth Factors on Embryonic Stem Cell Differentiation Inside of Fibrin Scaffolds , 2007, Stem cells.

[59]  Monica Siegenthaler,et al.  Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury , 2009, Stem cells.

[60]  D. Fischer,et al.  Histological and Functional Benefit Following Transplantation of Motor Neuron Progenitors to the Injured Rat Spinal Cord , 2010, PloS one.

[61]  M. Yap,et al.  mAb 84, a Cytotoxic Antibody that Kills Undifferentiated Human Embryonic Stem Cells via Oncosis , 2009, Stem cells.

[62]  S. Sakiyama-Elbert,et al.  Controlled Release of Neurotrophin-3 and Platelet-Derived Growth Factor from Fibrin Scaffolds Containing Neural Progenitor Cells Enhances Survival and Differentiation into Neurons in a Subacute Model of SCI , 2010, Cell transplantation.

[63]  S. Sakiyama-Elbert,et al.  Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. , 2010, Journal of biomedical materials research. Part A.

[64]  C. Cepeda,et al.  Dopamine and Glutamate in Huntington's Disease: A Balancing Act , 2010, CNS neuroscience & therapeutics.

[65]  J Q Trojanowski,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[66]  T. Quertermous,et al.  Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells , 2010, PloS one.

[67]  J. Mcdonald,et al.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord , 1999, Nature Medicine.

[68]  B. Winblad,et al.  Alzheimer's disease: clinical trials and drug development , 2010, The Lancet Neurology.

[69]  D. Gottlieb,et al.  Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. , 2006, Biomaterials.

[70]  S. Papapetropoulos.  Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2011 .

[71]  M. Beal,et al.  Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes , 2006, Nature Medicine.

[72]  H. Okano,et al.  Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury , 2009, PloS one.

[73]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[74]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[75]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[76]  M. Schachner,et al.  Cell adhesion molecule l1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. , 2005, Journal of neurotrauma.

[77]  S. Sakiyama-Elbert,et al.  Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. , 2010, Soft matter.

[78]  R. Barker,et al.  Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475 , 2002, Journal of neurology, neurosurgery, and psychiatry.

[79]  T. Deacon,et al.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[80]  M. Hoane,et al.  Transplantation of neuronal and glial precursors dramatically improves sensorimotor function but not cognitive function in the traumatically injured brain. , 2004, Journal of neurotrauma.

[81]  R. McKay,et al.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease , 2002, Nature.

[82]  F. Nishimura,et al.  Transplantation of embryonic stem cell-derived neural stem cells for spinal cord injury in adult mice , 2005, Neurological research.

[83]  F. Nishimura,et al.  Cotransplantation of Mouse Embryonic Stem Cells and Bone Marrow Stromal Cells following Spinal Cord Injury Suppresses Tumor Development , 2009, Cell transplantation.

[84]  A. Srivastava,et al.  Transplanted Embryonic Stem Cells Successfully Survive, Proliferate, and Migrate to Damaged Regions of the Mouse Brain , 2006, Stem cells.

[85]  Long-term fetal cell transplant in Huntington disease: stayin' alive. , 2007, Neurology.

[86]  P. Couraud,et al.  Rat Brain Endothelial Cell Lines for the Study of Blood–Brain Barrier Permeability and Transport Functions , 2005, Cellular and Molecular Neurobiology.

[87]  S. Rehen,et al.  Predifferentiated embryonic stem cells promote functional recovery after spinal cord compressive injury , 2010, Brain Research.

[88]  S. Whittemore,et al.  Functional Recovery in Traumatic Spinal Cord Injury after Transplantation of Multineurotrophin-Expressing Glial-Restricted Precursor Cells , 2005, The Journal of Neuroscience.

[89]  H. Keirstead,et al.  Derivation of high-purity oligodendroglial progenitors. , 2009, Methods in molecular biology.

[90]  D. G. Hall.  Fundamentals of neurobiology. , 2011 .

[91]  M. Molcanyi,et al.  Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. , 2007, Journal of neurotrauma.

[92]  M. Schuldiner,et al.  Selective Ablation of Human Embryonic Stem Cells Expressing a “Suicide” Gene , 2003, Stem cells.

[93]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.